Product Information
DM-GUAIF-PE 18-200-10 MG/15 ML is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0720 per ML under NDC 69367018408. Its NADAC has been published 259 times since May 23, 2018.
DM-GUAIF-PE 18-200-10 MG/15 ML
DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDEStrength
18; 200; 10 mg/15mL; mg/15mL; mg/15mL
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367018408
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/15/2018
Pharmacological Classes
Price Statistics
The NADAC for DM-GUAIF-PE 18-200-10 MG/15 ML has been published 259 times since May 23, 2018, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0720 per ML |
|---|---|
| All-time high | $0.1004 (Nov 13, 2019) |
| All-time low | $0.0690 (Jun 17, 2026) |
| 52-week high | $0.0742 |
| 52-week low | $0.0690 |
| Median price | $0.0967 |
| Average price | $0.0850 |
| Largest weekly change | -26.7% (Apr 17, 2024) |
| Weeks tracked | 259 |
| Tracking since | May 23, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DM-GUAIF-PE 18-200-10 MG/15 ML?
The current National Average Drug Acquisition Cost (NADAC) for DM-GUAIF-PE 18-200-10 MG/15 ML, manufactured by Westminster Pharmaceuticals LLC, is $0.0720 per ML (NDC 69367018408), effective Sep 30, 2026.
How has the price of DM-GUAIF-PE 18-200-10 MG/15 ML changed over time?
Over the history we have for it, the NADAC for DM-GUAIF-PE 18-200-10 MG/15 ML has declined 27.7%. It has been tracked across 259 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for DM-GUAIF-PE 18-200-10 MG/15 ML?
Since May 23, 2018, the NADAC for DM-GUAIF-PE 18-200-10 MG/15 ML has ranged from a low of $0.0690 (Jun 17, 2026) to a high of $0.1004 (Nov 13, 2019), with a median of $0.0967 per ML.
Are there cheaper alternatives to DM-GUAIF-PE 18-200-10 MG/15 ML?
No other NADAC-published product currently shares the active ingredient and strength of DM-GUAIF-PE 18-200-10 MG/15 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DM-GUAIF-PE 18-200-10 MG/15 ML?
DM-GUAIF-PE 18-200-10 MG/15 ML (NDC 69367018408) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.